Real-time enrollment status for this kras altered advanced or metastatic solid tumors clinical trial
Current Status
Recruiting
Checked: July 13, 2026 at 6:38 AM UTC
| NCT Number | NCT07094113 |
| Recruiting Status | Recruiting |
| Condition | KRAS Altered Advanced or Metastatic Solid Tumors |
| Phase | Clinical Trial |
| Target Enrollment | 434 participants |
| Active Locations | 10 sites in the US |
| Sponsor | Amgen |
| Last Updated on CT.gov | July 10, 2026 (3 days ago) |
As of July 13, 2026: Clinical trial NCT07094113 is currently recruiting participants. This clinical trial study for kras altered advanced or metastatic solid tumors is actively seeking new participants at 10 locations across the United States. The study is sponsored by Amgen. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07094113 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 10 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07094113 was last updated 3 days ago (July 10, 2026). HelloStudys verifies this status automatically.